欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Apoptosis-RIP kinase-YM-155
YM-155

Chemical Structure : YM-155

CAS No.: 781661-94-7

YM-155 (Sepantronium bromide, YM155)

货号: PC-42439Not For Human Use, Lab Use Only.

Sepantronium bromide (YM-155) is a potent, specific survivin inhibitor that inhibits survivin promoter activity with IC50 of 0.54 nM, targets RIPK2 kinase activity.

规格 价格 库存 数量
10 mg ¥780 In stock
25 mg ¥1280 In stock
50 mg ¥1980 In stock
100 mg ¥3280 In stock
250 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

Sepantronium bromide (YM-155) is a potent, specific survivin inhibitor that inhibits survivin promoter activity with IC50 of 0.54 nM, targets RIPK2 kinase activity.
YM-155 does not significantly inhibit SV40 promoter activity (>30 uM).
YM-155 suppresses expression of survivin and induces apoptosis in PC-3 and PPC-1 human HRPC cell lines at 10 nM, without effect on IAP- or Bcl-2-related proteins.
YM-155 induces massive tumor regression in PC-3 tumor mice model (3-10 mg/kg).

物理化学性质&存储条件

分子量 443.2939
分子式 C20H19BrN4O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20 °C 12 个月; 4°C 6 个月
配置液
-80 °C 6 个月; -20°C 6 个月
Shipping
Solubility

DMSO: 10.66 mg/mL

Chemical Name/SMILES

1H-Naphth[2,3-d]imidazolium, 4,9-dihydro-1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(2-pyrazinylmethyl)-, bromide (1:1)

参考文献

1. Nakahara T, et al. Cancer Res. 2007 Sep 1;67(17):8014-21.

2. Iwasa T, et al. Clin Cancer Res. 2008 Oct 15;14(20):6496-504.

3. Satoh T, et al. Clin Cancer Res. 2009 Jun 1;15(11):3872-80.

4. Iwasa T, et al. Br J Cancer. 2010 Jun 29;103(1):36-42.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: